The 1995 Walter Hubert Lecture--molecular Epidemiology of Human Cancer: Insights from the Mutational Analysis of the P53 Tumour-suppressor Gene

Overview

Journal Br J Cancer

Specialty Oncology

Date 1996 Feb 1

PMID 8562328

Citations 13

Authors

C C Harris

Affiliations

Soon will be listed here.

Citing Articles

Risk Assessment on Dietary Exposure to Aflatoxin B₁ in Post-Harvest Peanuts in the Yangtze River Ecological Region.

Ding X, Wu L, Li P, Zhang Z, Zhou H, Bai Y Toxins (Basel). 2015; 7(10):4157-74.

PMID: 26501322 PMC: 4626727. DOI: 10.3390/toxins7104157.

MicroRNA-125b is a novel negative regulator of p53.

Le M, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V Genes Dev. 2009; 23(7):862-76.

PMID: 19293287 PMC: 2666337. DOI: 10.1101/gad.1767609.

p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.

Vikhanskaya F, DIncalci M, Broggini M Nucleic Acids Res. 1999; 28(2):513-9.

PMID: 10606650 PMC: 102516. DOI: 10.1093/nar/28.2.513.

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver.

Tannapfel A, Engeland K, Weinans L, Katalinic A, Hauss J, Mossner J Br J Cancer. 1999; 80(7):1069-74.

PMID: 10362118 PMC: 2363034. DOI: 10.1038/sj.bjc.6690465.

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.

Berns E, van Staveren I, Look M, Smid M, Klijn J, Foekens J Br J Cancer. 1998; 77(7):1130-6.

PMID: 9569050 PMC: 2150115. DOI: 10.1038/bjc.1998.187.

References

Mack D, Vartikar J, Pipas J, Laimins L . Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature. 1993; 363(6426):281-3. DOI: 10.1038/363281a0. View

Liu X, Miller C, Koeffler P, Berk A . The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol Cell Biol. 1993; 13(6):3291-300. PMC: 359782. DOI: 10.1128/mcb.13.6.3291-3300.1993. View

Dittmer D, Pati S, Zambetti G, Chu S, Teresky A, Moore M . Gain of function mutations in p53. Nat Genet. 1993; 4(1):42-6. DOI: 10.1038/ng0593-42. View

Martin D, Munoz R, Subler M, Deb S . p53 binds to the TATA-binding protein-TATA complex. J Biol Chem. 1993; 268(18):13062-7. View

Kunkel T . Nucleotide repeats. Slippery DNA and diseases. Nature. 1993; 365(6443):207-8. DOI: 10.1038/365207a0. View

Aguilar F, Hussain S, Cerutti P . Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci U S A. 1993; 90(18):8586-90. PMC: 47402. DOI: 10.1073/pnas.90.18.8586. View

Harris C, Hollstein M . Clinical implications of the p53 tumor-suppressor gene. N Engl J Med. 1993; 329(18):1318-27. DOI: 10.1056/NEJM199310283291807. View

Levine A, Momand J, Finlay C . The p53 tumour suppressor gene. Nature. 1991; 351(6326):453-6. DOI: 10.1038/351453a0. View

Hollstein M, Sidransky D, Vogelstein B, Harris C . p53 mutations in human cancers. Science. 1991; 253(5015):49-53. DOI: 10.1126/science.1905840. View

10.

Shields P, Harris C . Molecular epidemiology and the genetics of environmental cancer. JAMA. 1991; 266(5):681-7. View

11.

Harris C . Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res. 1991; 51(18 Suppl):5023s-5044s. View

12.

Hino O, Tabata S, Hotta Y . Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA. Proc Natl Acad Sci U S A. 1991; 88(20):9248-52. PMC: 52691. DOI: 10.1073/pnas.88.20.9248. View

13.

Brash D, Rudolph J, Simon J, Lin A, McKenna G, Baden H . A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A. 1991; 88(22):10124-8. PMC: 52880. DOI: 10.1073/pnas.88.22.10124. View

14.

Evans M, Taffe B, Harris C, Bohr V . DNA strand bias in the repair of the p53 gene in normal human and xeroderma pigmentosum group C fibroblasts. Cancer Res. 1993; 53(22):5377-81. View

15.

Harris C . p53: at the crossroads of molecular carcinogenesis and risk assessment. Science. 1993; 262(5142):1980-1. DOI: 10.1126/science.8266092. View

16.

Bakalkin G, Yakovleva T, Selivanova G, Magnusson K, Szekely L, Kiseleva E . p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc Natl Acad Sci U S A. 1994; 91(1):413-7. PMC: 42958. DOI: 10.1073/pnas.91.1.413. View

17.

Unsal H, Yakicier C, Marcais C, Kew M, Volkmann M, Zentgraf H . Genetic heterogeneity of hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1994; 91(2):822-6. PMC: 43041. DOI: 10.1073/pnas.91.2.822. View

18.

Levine A, Perry M, Chang A, Silver A, Dittmer D, Wu M . The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer. 1994; 69(3):409-16. PMC: 1968876. DOI: 10.1038/bjc.1994.76. View

19.

Tornaletti S, Pfeifer G . Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science. 1994; 263(5152):1436-8. DOI: 10.1126/science.8128225. View

20.

Wang X, Forrester K, Yeh H, Feitelson M, Gu J, Harris C . Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A. 1994; 91(6):2230-4. PMC: 43344. DOI: 10.1073/pnas.91.6.2230. View